What is the recommended diagnostic workup and treatment strategy for eosinophilic colitis?

Eosinophilic Colitis: Diagnostic Workup and Treatment Strategy

I need to clarify that the provided evidence focuses almost entirely on eosinophilic esophagitis (EoE), not eosinophilic colitis (EC), which are distinct entities within the spectrum of eosinophilic gastrointestinal disorders. The guidelines 1 and recent perspectives 2 all address esophageal disease specifically. For eosinophilic colitis, I must rely on the research literature 3, 4, 5, 6, 7, 8, 9 and general medical knowledge, as no validated guidelines currently exist for EC.

Diagnostic Workup

Clinical Presentation to Recognize

In adults: Look for chronic diarrhea (most common) and abdominal pain as the primary symptoms 4, 5. Unlike EoE which presents with dysphagia, EC manifests with lower GI symptoms. Some patients present with GI bleeding, weight loss, or acute complications like hemoperitoneum 8.

In children: Symptoms are broader and include recurrent abdominal pain (66%), chronic diarrhea (64%), chronic constipation (8%), and occasionally GI bleeding 6. Notably, there's a significantly higher prevalence in children with autism spectrum disorder (44% vs 28.5% in general population, p=0.03) 6.

Key Diagnostic Steps

Endoscopy with multiple biopsies is mandatory - this is a diagnosis that requires histologic confirmation 3, 4, 5. The macroscopic appearance is often normal or shows only lymphoid nodular hypertrophy, making visual inspection unreliable 6, 9.

Biopsy requirements:

• Obtain biopsies from multiple colonic segments (right colon, transverse colon, left colon, sigmoid, rectum)
• The histologic threshold remains controversial, but Collins' criteria suggest: >100 eosinophils/HPF in right colon, >84 eosinophils/HPF in transverse and left colon, >64 eosinophils/HPF in sigmoid and rectum 6
• Alternative threshold: >40 eosinophils/HPF in at least two different colonic segments 4

Critical pitfall: EC is frequently misdiagnosed as inflammatory bowel disease (IBD) 9. The key differentiator is the predominance of eosinophils on histology. Proactive communication between endoscopist and pathologist is essential - specifically request eosinophil counts in the pathology report 9.

Exclusion of Secondary Causes (Diagnosis of Exclusion)

Before diagnosing primary EC, systematically exclude 3, 4, 5:

• Parasitic infections - stool studies for ova and parasites
• Drug reactions - review medication history (NSAIDs, antibiotics, others)
• Food allergens - though skin testing has limited value in adults 4
• Other conditions: IBD, GVHD, connective tissue diseases, hypereosinophilic syndrome

Laboratory workup:

• Complete blood count - peripheral eosinophilia is present in many cases and facilitates diagnosis 9
• Consider IgE levels and allergy testing, though these have limited diagnostic value in adults 4
• In children, check for history of atopy and allergies (present in only 14% of cases) 6

Treatment Strategy

First-Line Treatment

Systemic corticosteroids are the most effective initial therapy based on available evidence 3, 4, 5, 7. While no standardized protocols exist, the literature supports:

• Oral prednisone or equivalent as primary treatment
• Duration typically 2-4 weeks with gradual taper
• Clinical response usually occurs within one week 7

Budesonide has demonstrated potential efficacy and may be preferred for its lower systemic side effect profile 4.

Adjunctive and Alternative Therapies

Antihistamines can be added to corticosteroids, particularly in patients with atopic features 7.

Dietary elimination is less effective in adults compared to children, as IgE-mediated allergic reactions are rarely identified 4. Six-food elimination diet may be considered in refractory cases, but requires dietitian support (extrapolating from EoE guidelines 1).

Mesalamine (5-ASA) has been used in some cases 6, though evidence is limited. Treatment failure with 5-ASA should prompt reconsideration of the diagnosis 9.

Treatment Monitoring

Repeat endoscopy with biopsies is necessary to assess histologic response 6. A critical finding: 75% of patients show histologic persistence of eosinophils even with symptom relief 6. This dissociation between clinical and histologic response complicates management decisions.

Maintenance therapy: Given the high relapse rate seen in EoE after steroid withdrawal 1, consider maintenance treatment in EC, though specific protocols are not established.

Refractory Disease

For patients not responding to corticosteroids:

• Re-evaluate for secondary causes
• Consider surgical consultation if complications develop (perforation, obstruction, severe hemorrhage) 8
• Novel biologics (dupilumab, others) show promise in eosinophilic GI disorders 1, 10 but lack specific evidence for EC

Critical Clinical Pearls

The absence of validated guidelines makes EC management challenging 3, 5. Most evidence derives from case reports and small series, limiting treatment recommendations.

Normal endoscopic appearance does not exclude EC - always biopsy when clinical suspicion exists 6, 7.

Peripheral eosinophilia facilitates diagnosis but is not required 9.

Multidisciplinary approach: Consider gastroenterology and allergy co-management, particularly in refractory cases or those with significant atopic disease (extrapolating from EoE recommendations 1).